Bhogal-Bhamra Gurpreet K, Aujla Maana, Kolli Sai, Sheppard Amy L, Wolffsohn James S
Ophthalmic Research Group, Aston University, Birmingham, United Kingdom.
University Hospitals Trust, Ophthalmology, Queen Elizabeth Hospital, Birmingham, United Kingdom.
Front Ophthalmol (Lausanne). 2024 Apr 25;4:1310468. doi: 10.3389/fopht.2024.1310468. eCollection 2024.
Glare is a known side effect of intraocular lens (IOL) implantation, affected principally by IOL material and optics, although it is reported subjectively to decrease in impact with time. However, little objective data have been published on changes over time, how these relate to subjective reports, and whether those who will report greater glare symptoms can be predicted prior to IOL implantation.
A total of 32 patients (aged 72.4 ± 8.0 years) with healthy eyes were implanted bilaterally with hydrophilic 600s (Rayner, Worthing, UK) or hydrophobic Acrysof (Alcon, Texas, USA) acrylic IOLs ( = 16 each, randomly assigned). Each patient reported their dysphotopsia symptoms subjectively using the validated forced choice photographic questionnaire for photic phenomena, and halo size resulting from a bright light in a dark environment was quantified objectively in eight orientations using the Aston Halometer. Assessment was performed binocularly pre-operatively and at 1, 2, 3, and 4 weeks after IOL implantation.
The study was carried out at the National Health Service Ophthalmology Department, Queen Elizabeth Hospital, Birmingham, UK.
Visual acuity (average 0.37 ± 0.26 logMAR) did not correlate with subjective glare ( = 0.184, = 0.494) or objective glare ( = 0.294, = 0.270) pre-surgery. Objective halo size ( = 112.781, < 0.001) decreased with cataract removal and IOL implantation and continued to decreased over the month after surgery. Subjective dysphotopsia complaints ( < 0.001) were also greater pre-surgery, but did not change thereafter ( = 0.228). In neither case was there a difference with IOL material ( > 0.05). It was not possible to predict post-surgery dysphotopsia from symptoms or a ratio of symptoms to halo size pre-surgery ( > 0.05).
Subjective dysphotopsia and objective halos caused by cataracts are greatly reduced by implantation of IOL after cataract removal causing few perceivable symptoms. However, objective measures are able to quantify a further reduction in light scatter over the first month post-IOL implantation, suggesting that any subjective effects over this period are due to the healing process and not due to neuroadaptation.
眩光为人工晶状体(IOL)植入术后已知的一种副作用,主要受IOL材料和光学特性影响,尽管有主观报告称随着时间推移其影响会减弱。然而,关于随时间变化的客观数据、这些变化与主观报告之间的关系以及能否在IOL植入术前预测哪些患者会报告更严重的眩光症状,目前发表的资料较少。
共有32例(年龄72.4±8.0岁)双眼健康的患者,分别植入亲水性600s(Rayner公司,英国沃辛)或疏水性Acrysof(爱尔康公司,美国得克萨斯州)丙烯酸酯IOL(各16例,随机分配)。每位患者使用经过验证的用于光现象的强制选择摄影问卷主观报告其畏光症状,并使用阿斯顿光晕计在八个方向上客观量化黑暗环境中强光产生的光晕大小。在IOL植入术前及术后1、2、3和4周进行双眼评估。
该研究在英国伯明翰伊丽莎白女王医院的国民保健服务眼科部开展。
术前视力(平均0.37±0.26 logMAR)与主观眩光(r = 0.184,P = 0.494)或客观眩光(r = 0.294,P = 0.270)均无相关性。随着白内障摘除和IOL植入,客观光晕大小(F = 112.781,P < 0.001)减小,且在术后1个月内持续减小。主观畏光症状主诉术前也更多(P < 0.001),但此后无变化(P = 0.228)。两种情况均未发现IOL材料有差异(P > 0.05)。无法根据术前症状或症状与光晕大小的比值预测术后畏光症状(P > 0.05)。
白内障摘除后植入IOL可使白内障引起的主观畏光和客观光晕大幅减轻,几乎不会引起可察觉的症状。然而,客观测量能够量化IOL植入术后第一个月内光散射的进一步减少,这表明在此期间的任何主观影响是由于愈合过程而非神经适应。